Integral Diagnostics Limited

ASX IDX.AX

Integral Diagnostics Limited Cash and Short-Term Investments for the year ending June 30, 2024: USD 28.30 M

Integral Diagnostics Limited Cash and Short-Term Investments is USD 28.30 M for the year ending June 30, 2024, a 25.59% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Integral Diagnostics Limited Cash and Short-Term Investments for the year ending June 30, 2023 was USD 22.53 M, a -73.50% change year over year.
Integral Diagnostics Limited Cash and Short-Term Investments for the year ending June 30, 2022 was USD 85.02 M, a 82.29% change year over year.
Integral Diagnostics Limited Cash and Short-Term Investments for the year ending June 30, 2021 was USD 46.64 M, a 16.56% change year over year.
Integral Diagnostics Limited Cash and Short-Term Investments for the year ending June 30, 2020 was USD 40.01 M, a 171.78% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

ASX: IDX.AX

Integral Diagnostics Limited

CEO	Dr. Ian Kadish M.B.A., MBBCh
IPO Date	Oct. 20, 2015
Location	Australia
Headquarters	45 William Street
Employees	1,977
Sector	Healthcare
Industries Telehealth 3D Printing Biotechnology Defense & Military Dental Care Health Insurance & Plans Hospitals & Clinics Medical Instruments

Description

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Key trends

Past 5 years